Contact person : Vincent Bouchiat –

Location: Grenoble, France

Year of creation: 2019

Type of technology:

Grapheal is a medtech company focusing on wearable biosensors for field diagnostic kits & smart bandages . Grapheal merges digital bioelectronic sensing technologies based on graphene transistors with connectivity into embedded systems for on-site diagnostics and remote patient monitoring. Current applications are wound care digital assistant for improving the follow-up of difficult to heal wounds and a digital Covid-19 test for rapid screening at high-traffic areas such as airports.

Product solutions:

Smart bandages and Wearables sensors for remote patient monitoring and field diagnostics.

Other possible applications of their technology:

  • Sweat analysis
  • Wearables Glucose sensors for diabetics
  • Water quality assessment

Experience and/or interest in financing their product development through publicly funded projects:

Grapheal has been awarded public funded grant from French ministry of Research, French Research Agency (ANR), European Institute of Technology (EIT-Health). Grapheal is also an associate member of EU supported Graphene Flagship.

Disruptive innovation (s) :

Grapheal is the only company selling products such as wearable and biosensor based  on monolayer graphene-on-polymer technology.

Its proprietary technology enables the large scale production of biocompatible flexible and transparent sensing material at low cost.

Its stand alone smartphone-operated  wireless sensors is going to have  a selling price tag well below 10€) .

GRAPHEAL  is also the only French company focusing on the healthcare applications of Graphene.